Jeff Johnson
Stock Analyst at Baird
(4.63)
# 189
Out of 4,944 analysts
145
Total ratings
57.14%
Success rate
29.94%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Maintains: Neutral | $15 → $17 | $15.10 | +12.58% | 2 | Jul 30, 2025 | |
| HSIC Henry Schein | Downgrades: Neutral | $82 → $72 | $68.99 | +4.36% | 10 | Jul 14, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $107 → $97 | $74.27 | +30.60% | 17 | May 30, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $21.56 | +6.68% | 10 | May 27, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $130 → $115 | $103.22 | +11.41% | 14 | May 6, 2025 | |
| DXCM DexCom | Maintains: Outperform | $115 → $105 | $79.96 | +31.32% | 14 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $33 → $24 | $11.13 | +115.63% | 16 | May 1, 2025 | |
| ALC Alcon | Maintains: Outperform | $104 → $108 | $86.48 | +24.88% | 9 | Feb 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $378.95 | +6.87% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $145.74 | +89.38% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $308.68 | -22.90% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $29.59 | +136.57% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $14.65 | +316.38% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $13.85 | +383.75% | 6 | Feb 18, 2022 |
Beta Bionics
Jul 30, 2025
Maintains: Neutral
Price Target: $15 → $17
Current: $15.10
Upside: +12.58%
Henry Schein
Jul 14, 2025
Downgrades: Neutral
Price Target: $82 → $72
Current: $68.99
Upside: +4.36%
The Cooper Companies
May 30, 2025
Maintains: Outperform
Price Target: $107 → $97
Current: $74.27
Upside: +30.60%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $21.56
Upside: +6.68%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $130 → $115
Current: $103.22
Upside: +11.41%
DexCom
May 2, 2025
Maintains: Outperform
Price Target: $115 → $105
Current: $79.96
Upside: +31.32%
Tandem Diabetes Care
May 1, 2025
Maintains: Neutral
Price Target: $33 → $24
Current: $11.13
Upside: +115.63%
Alcon
Feb 27, 2025
Maintains: Outperform
Price Target: $104 → $108
Current: $86.48
Upside: +24.88%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $378.95
Upside: +6.87%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $145.74
Upside: +89.38%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $308.68
Upside: -22.90%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $29.59
Upside: +136.57%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $14.65
Upside: +316.38%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $13.85
Upside: +383.75%